BENZOYL PEROXIDE; TRETINOIN - Generic Drug Details

What are the generic drug sources for benzoyl peroxide; tretinoin and what is the scope of freedom to operate?

Benzoyl peroxide; tretinoin is the generic ingredient in one branded drug marketed by Mayne Pharma and is included in one NDA. There are thirteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Benzoyl peroxide; tretinoin has one hundred and seven patent family members in eighteen countries.

Two suppliers are listed for this compound.

Summary for BENZOYL PEROXIDE; TRETINOIN

International Patents:	107
US Patents:	13
Tradenames:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	2
Clinical Trials:	9
DailyMed Link:	BENZOYL PEROXIDE; TRETINOIN at DailyMed

DrugPatentWatch^® Estimated Loss of Exclusivity (LOE) Date for BENZOYL PEROXIDE; TRETINOIN

Constraining patent/regulatory exclusivity:

11,071,878

Dosage:

CREAM;TOPICAL

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for BENZOYL PEROXIDE; TRETINOIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
GWT-TUD GmbH	Phase 4
Galderma Laboratories, L.P.	Phase 4
Zeichner, Joshua, M.D.	Phase 4

See all BENZOYL PEROXIDE; TRETINOIN clinical trials

Pharmacology for BENZOYL PEROXIDE; TRETINOIN

Drug Class

Retinoid

Anatomical Therapeutic Chemical (ATC) Classes for BENZOYL PEROXIDE; TRETINOIN

D10AD	Retinoids for topical use in acne
D10A	ANTI-ACNE PREPARATIONS FOR TOPICAL USE
D10	ANTI-ACNE PREPARATIONS
D	Dermatologicals

D10AE	Peroxides
D10A	ANTI-ACNE PREPARATIONS FOR TOPICAL USE
D10	ANTI-ACNE PREPARATIONS
D	Dermatologicals

L01XF	Retinoids for cancer treatment
L01X	OTHER ANTINEOPLASTIC AGENTS
L01	ANTINEOPLASTIC AGENTS
L	Antineoplastic and immunomodulating agents

US Patents and Regulatory Information for BENZOYL PEROXIDE; TRETINOIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mayne Pharma	TWYNEO	benzoyl peroxide; tretinoin	CREAM;TOPICAL	214902-001	Jul 26, 2021		RX	Yes	Yes	12,070,629		Y
Mayne Pharma	TWYNEO	benzoyl peroxide; tretinoin	CREAM;TOPICAL	214902-001	Jul 26, 2021		RX	Yes	Yes	12,295,935
Mayne Pharma	TWYNEO	benzoyl peroxide; tretinoin	CREAM;TOPICAL	214902-001	Jul 26, 2021		RX	Yes	Yes	12,156,946		Y
Mayne Pharma	TWYNEO	benzoyl peroxide; tretinoin	CREAM;TOPICAL	214902-001	Jul 26, 2021		RX	Yes	Yes	12,133,919		Y
Mayne Pharma	TWYNEO	benzoyl peroxide; tretinoin	CREAM;TOPICAL	214902-001	Jul 26, 2021		RX	Yes	Yes	12,053,546		Y
Mayne Pharma	TWYNEO	benzoyl peroxide; tretinoin	CREAM;TOPICAL	214902-001	Jul 26, 2021		RX	Yes	Yes	12,491,163		Y
Mayne Pharma	TWYNEO	benzoyl peroxide; tretinoin	CREAM;TOPICAL	214902-001	Jul 26, 2021		RX	Yes	Yes	11,071,878		Y

International Patents for BENZOYL PEROXIDE; TRETINOIN

Country	Patent Number	Title	Estimated Expiration
Spain	3040940
Japan	5934107
European Patent Office	3698778	FORMULATIONS TOPIQUES STABILISÉES CONTENANT DES MICROCAPSULES C UR-ÉCORCE (STABILIZED TOPICAL FORMULATIONS CONTAINING CORE-SHELL MICROCAPSULES)
Eurasian Patent Organization	015815	ПОКРЫТИЕ ИЗ ОКСИДА МЕТАЛЛА ДЛЯ ВОДОНЕРАСТВОРИМЫХ ИНГРЕДИЕНТОВ (METAL OXIDE COATING OF WATER INSOLUBLE INGREDIENTS)
Brazil	112013031813	composição para aplicação tópica
Australia	2008211554	Method for preparing particles comprising metal oxide coating and particles with metal oxide coating
Japan	2010517997

Supplementary Protection Certificates for BENZOYL PEROXIDE; TRETINOIN

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0186118	SPC/GB05/029	United Kingdom		PRODUCT NAME: MESOTRIONE (2-(4-METHYLSULPHONYL-2-NITROBENZOYL)-1,3CYCLOHEXANEDIONE); REGISTERED: AU 2726 20001016; UK 0309 OF 2005 20050218
1458369	CA 2008 00029	Denmark		PRODUCT NAME: ADAPALEN, BENZOYLPEROXID
0526708	C300097	Netherlands		PRODUCT NAME: BOSENTAN, DESGEWENST IN DE VORM VAN EEN ZOUT OF EEN HYDRAAT OF IN DE VORM VAN EEN ESTER VAN DE HYDROXYLGROEP VAN DE 2-HYDROXYETHOXY REST MET EEN ZUUR MET DE FORMULE R5-OH, WAARIN R5 EEN C1-7-ALKANOYL, BENZOYL, OF HETEROCYCLYCARBONYL VOORSTELT; NATL. REGISTRATION NO/DATE: U/1/02/220/001 - 005 20020515; FIRST REGISTRATION: CH IKS 58841 01 - 02 20020228
1458369	122008000041	Germany		PRODUCT NAME: ADAPALEN IN KOMBINATION MIT BENZOYLPEROXID; NAT. REGISTRATION NO/DATE: 67913.00.00 20080229; FIRST REGISTRATION: DAENEMARK 40440 20071218
1586316	SPC/GB11/054	United Kingdom		PRODUCT NAME: BROMFENAC 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID OR A PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF OR A HYDRATE THEREOF; REGISTERED: UK EU/1/11/692/001 20110523
1667986	92172	Luxembourg		PRODUCT NAME: SOLVAT ACETONIQUE DU CABAZITAXEL, OU DESIGNE SOLVAT ACETONIQUE DU DIMETHOXY DOCETAXEL OU SOLVAT ACETONIQUE DU (2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DE 4-ACETOXY-2A-BENZOYLOXY-5BETA,20-EPOXY-1-HYDROXY-7BETA,10A-DIMETHOXY-9-OXO-TAX-11-ENE-13A-YLE(ACETONATE DU CABAZITAXEL)
0591275	SPC/GB05/030	United Kingdom		PRODUCT NAME: NITISINONE (2-(2-NITRO-4-TRIFLUOROMETHYLBENZOYL)-1,3-CYCLOHEXANEDIONE) OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK EU/1/04/303/001 20050221; UK EU/1/04/303/002 20050221; UK EU/1/04/303/003 20050221

BENZOYL PEROXIDE; TRETINOIN Market Analysis and Financial Projection

Last updated: February 15, 2026

What Are the Market Dynamics for Benzoyl Peroxide and Tretinoin?

The global market for both benzoyl peroxide and tretinoin is shaped by increasing demand for dermatological treatments, regulatory pathways, and consumer preferences. The acne treatment segment dominates the market for these products, driven by rising incidences of acne in adolescents and adults and increasing awareness about skin health.

Benzoyl Peroxide Market Dynamics

Benzoyl peroxide (BPO) is an over-the-counter and prescription medication primarily used for acne vulgaris. The market is characterized by:

• High availability across retail channels: Wide distribution through pharmacies and online platforms.
• Price sensitivity: Many formulations are inexpensive, which supports accessibility.
• Regulatory status: Approved globally for topical use; some formulations are available as generics, creating pricing competition.
• Consumer preference: Growing preference for OTC products over prescription medications due to ease of access.

Market size (2022): Estimated at approximately USD 400 million globally, with North America leading (around 45%), followed by Europe and Asia-Pacific.

Growth rate: Compound annual growth rate (CAGR) of approximately 5-6% projected from 2023 to 2030, driven by increasing acne cases and consumer demand for OTC solutions.

Key factors influencing growth: Product innovation (combining benzoyl peroxide with other actives), rising skin health awareness, and shifting preference toward dermatology OTC products without the need for physicians' prescriptions.

Tretinoin Market Dynamics

Tretinoin, a retinoid used for acne, photoaging, and certain keratinization disorders, has a more complex market landscape:

• Prescription-only status: In many regions, tretinoin remains prescription-based, owing to regulatory controls and potential side effects.
• Brand dominance: Market is highly dominated by established brands like Retin-A (Johnson & Johnson), Renova, and other generics.
• Demand drivers: Aging population and increasing use for anti-aging treatments; rising prevalence of acne.
• Market entry barriers: Regulatory approvals, patent protections, and significant R&D investments.

Market size (2022): Estimated at approximately USD 800 million globally, with North America accounting for roughly 50%. Europe and Asia-Pacific follow.

Growth rate: CAGR of around 4-5% expected through 2023-2030, data indicates steady, moderate growth influenced by aging demographics and rising skin health awareness.

Market constraints: Concerns about side effects like irritation and photosensitivity limit broader adoption. Regulations limit OTC availability, restricting rapid market expansion compared to benzoyl peroxide.

How Are Regulatory and Competitive Factors Influencing These Markets?

• Regulatory landscape: Benzoyl peroxide faces fewer regulatory hurdles, facilitating OTC availability. Tretinoin’s registration as a prescription drug limits rapid market expansion but protects high-margin branded formulations.

• Patent expirations: Many tretinoin formulations are off-patent, enabling generic manufacturing and price competition. Benzoyl peroxide formulations are largely unpatented, encouraging multiple players and competitive pricing.

• New formulations: Both markets experience innovation, such as combination therapies (e.g., benzoyl peroxide with adapalene) and novel delivery systems, aiming to improve efficacy and tolerability.

• Market consolidation: Larger pharmaceutical companies dominate the tretinoin market through established brands, while the benzoyl peroxide segment has many generic and private-label products.

What Are the Key Financial Trends?

Metric	Benzoyl Peroxide	Tretinoin
Market Size (2022)	USD 400 million	USD 800 million
CAGR (2023-2030)	5-6%	4-5%
Leading Regions	North America (45%), Europe, Asia-Pacific	North America (50%), Europe, Asia-Pacific
Price Range	USD 2 to USD 10 per tube or bottle	USD 50 to USD 150 per prescription
Patent Status	Generic, widespread availability	Off-patent with some proprietary formulations

Financial Outlook

Benzoyl peroxide's growth continues to be supported by its OTC nature and high affordability, leading to stable revenue streams. The tretinoin market sustains margins through branded formulations, but growth is constrained by regulatory restrictions and side effects.

Market expansion hinges on product innovation, expanding regions, and consumer acceptance. Patent expirations in tretinoin-open generic markets will aid competition and price reduction, potentially lowering margins in the short term.

What Are the Risks and Opportunities?

Risks

• Regulatory restrictions on tretinoin may limit growth.
• Side effects and safety concerns can hinder consumer adoption for both drugs.
• Market saturation, especially for benzoyl peroxide.
• Competition from newer alternative therapies, including laser treatments and other topicals.

Opportunities

• Increasing skin health awareness in emerging markets.
• Development of combination products (e.g., benzoyl peroxide with antibiotics or retinoids).
• Personalized dermatology treatments driven by advancements in skin analysis.
• Expansion into markets with rising income levels and expanding pharmaceutical distribution channels.

Key Takeaways

• Benzoyl peroxide holds a USD 400 million market, growing at 5-6%, driven by OTC availability and affordability.
• Tretinoin's market size stands at USD 800 million, with steady growth limited by its prescription-only status.
• Both markets are influenced by regulatory landscapes, patent statuses, and product innovation.
• Growth prospects depend on consumer preferences, regional expansion, and advanced formulation strategies.
• Regulatory changes or new formulations could significantly alter competitive dynamics.

FAQs

1. How will patent expirations impact the tretinoin market?
Patent expirations will introduce more generic options, reducing prices and potentially lowering profit margins for branded tretinoin products but increasing access and volume sales.

2. Are there emerging markets for benzoyl peroxide?
Yes. Markets such as India, Southeast Asia, and Latin America show increasing demand due to rising disposable income and awareness about skin health.

3. How does the safety profile influence market growth?
Concerns over side effects such as irritation and photosensitivity limit use, particularly in tretinoin, affecting market size and growth.

4. What role do combination therapies play?
They expand use cases, improve efficacy, and reduce side effects, opening new revenue channels and competitive advantages.

5. Will OTC availability for tretinoin increase?
It depends on regional regulatory decisions. Some regions may loosen restrictions if safety profiles are better established, expanding accessible treatment options and market size.

---

Sources:
[1] MarketWatch, "Global Benzoyl Peroxide Market Size and Forecast" (2022).
[2] GlobalData, "Tretinoin Market Overview", 2022.
[3] IQVIA, "Dermatology Market Insights", 2022.